| Followers | 65 |
| Posts | 23895 |
| Boards Moderated | 0 |
| Alias Born | 11/23/2016 |
Tuesday, January 23, 2024 12:44:05 PM
Late-Stage Pipeline has Achieved Clinical Milestones for Ongoing Development
A company that had truly met all endpoints in Pivotal Trials would not be using that heading for their late stage programme unless they expect to run more trials in those A2-73 indications.
I believe based on the totality of data, safety and unmet need that the chance of approval in Rett and AD are non-zero, but can't reconcile the results of the EXCELLENCE and P2b/3 AD trials with having chances > 50% - sorry!
Notice also the placement of the EXCELLENCE trial on the Stage timeline as apposed to the AVATAR trial.
Now let the emoji disapprovals nonsense crew have their fun.
The longer we wait, the sooner we will get rich!
Recent AVXL News
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
